Cargando…
OLFML2A Overexpression Predicts an Unfavorable Prognosis in Patients with AML
BACKGROUND: Acute myeloid leukemia (AML) is a malignant clonal disease of the myeloid hematopoietic system. Clinically, standard treatment options include conventional chemotherapy as well as hematopoietic stem cell transplantation. Among them, chemotherapy has a remission rate of 60% to 80% and nea...
Autores principales: | Lu, Xuan, Li, Ying, Yang, Yan, Zhuang, Wanchuan, Chai, Xingxing, Gong, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977544/ https://www.ncbi.nlm.nih.gov/pubmed/36873740 http://dx.doi.org/10.1155/2023/6017852 |
Ejemplares similares
-
Galectin-9 and PSMB8 overexpression predict unfavorable prognosis in patients with AML
por: Zhang, Yongping, et al.
Publicado: (2021) -
Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools
por: Liu, Jiaxin, et al.
Publicado: (2019) -
Correction to: Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools
por: Liu, Jiaxin, et al.
Publicado: (2019) -
Olfactomedin-like 2 A and B (OLFML2A and OLFML2B) expression profile in primates (human and baboon)
por: Pérez-Ibave, Diana Cristina, et al.
Publicado: (2016) -
Pan-Cancer Analysis of OLFML2B Expression and Its Association With Prognosis and Immune Infiltration
por: Hu, Pengbo, et al.
Publicado: (2022)